Literature DB >> 20371345

Matrix metalloproteinases: regulators of the tumor microenvironment.

Kai Kessenbrock1, Vicki Plaks, Zena Werb.   

Abstract

Extracellular proteolysis mediates tissue homeostasis. In cancer, altered proteolysis leads to unregulated tumor growth, tissue remodeling, inflammation, tissue invasion, and metastasis. The matrix metalloproteinases (MMPs) represent the most prominent family of proteinases associated with tumorigenesis. Recent technological developments have markedly advanced our understanding of MMPs as modulators of the tumor microenvironment. In addition to their role in extracellular matrix turnover and cancer cell migration, MMPs regulate signaling pathways that control cell growth, inflammation, or angiogenesis and may even work in a nonproteolytic manner. These aspects of MMP function are reorienting our approaches to cancer therapy. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20371345      PMCID: PMC2862057          DOI: 10.1016/j.cell.2010.03.015

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  131 in total

Review 1.  Matrix metalloproteinases as modulators of inflammation.

Authors:  Anne M Manicone; John K McGuire
Journal:  Semin Cell Dev Biol       Date:  2007-07-10       Impact factor: 7.727

2.  Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain.

Authors:  Javier Redondo-Muñoz; Estefanía Ugarte-Berzal; María José Terol; Philippe E Van den Steen; Mercedes Hernández del Cerro; Martin Roderfeld; Elke Roeb; Ghislain Opdenakker; José A García-Marco; Angeles García-Pardo
Journal:  Cancer Cell       Date:  2010-02-17       Impact factor: 31.743

3.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Authors:  Kandice R Levental; Hongmei Yu; Laura Kass; Johnathon N Lakins; Mikala Egeblad; Janine T Erler; Sheri F T Fong; Katalin Csiszar; Amato Giaccia; Wolfgang Weninger; Mitsuo Yamauchi; David L Gasser; Valerie M Weaver
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

4.  Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis.

Authors:  Veronica C Ardi; Tatyana A Kupriyanova; Elena I Deryugina; James P Quigley
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

Review 5.  Emerging roles of proteases in tumour suppression.

Authors:  Carlos López-Otín; Lynn M Matrisian
Journal:  Nat Rev Cancer       Date:  2007-10       Impact factor: 60.716

6.  Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature.

Authors:  Shihui Liu; Hailun Wang; Brooke M Currie; Alfredo Molinolo; Howard J Leung; Mahtab Moayeri; John R Basile; Randall W Alfano; J Silvio Gutkind; Arthur E Frankel; Thomas H Bugge; Stephen H Leppla
Journal:  J Biol Chem       Date:  2007-11-01       Impact factor: 5.157

7.  HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion.

Authors:  Rose Du; Kan V Lu; Claudia Petritsch; Patty Liu; Ruth Ganss; Emmanuelle Passegué; Hanqiu Song; Scott Vandenberg; Randall S Johnson; Zena Werb; Gabriele Bergers
Journal:  Cancer Cell       Date:  2008-03       Impact factor: 31.743

8.  Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells.

Authors:  G-One Ahn; J Martin Brown
Journal:  Cancer Cell       Date:  2008-03       Impact factor: 31.743

9.  In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer.

Authors:  Emilia S Olson; Todd A Aguilera; Tao Jiang; Lesley G Ellies; Quyen T Nguyen; Edmund H Wong; Larry A Gross; Roger Y Tsien
Journal:  Integr Biol (Camb)       Date:  2009-05-11       Impact factor: 2.192

10.  Force-induced unfolding of fibronectin in the extracellular matrix of living cells.

Authors:  Michael L Smith; Delphine Gourdon; William C Little; Kristopher E Kubow; R Andresen Eguiluz; Sheila Luna-Morris; Viola Vogel
Journal:  PLoS Biol       Date:  2007-10-02       Impact factor: 8.029

View more
  1670 in total

1.  Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1.

Authors:  Jennifer Vandooren; Benjamin Born; Inna Solomonov; Ewa Zajac; Radka Saldova; Michael Senske; Estefanía Ugarte-Berzal; Erik Martens; Philippe E Van den Steen; Jo Van Damme; Angeles Garcia-Pardo; Matheus Froeyen; Elena I Deryugina; James P Quigley; Søren K Moestrup; Pauline M Rudd; Irit Sagi; Ghislain Opdenakker
Journal:  Biochem J       Date:  2015-01-15       Impact factor: 3.857

2.  Constitutive K-RasG12D activation of ERK2 specifically regulates 3D invasion of human pancreatic cancer cells via MMP-1.

Authors:  Gregory P Botta; Mauricio J Reginato; Maximilian Reichert; Anil K Rustgi; Peter I Lelkes
Journal:  Mol Cancer Res       Date:  2011-12-08       Impact factor: 5.852

Review 3.  Cell invasion through basement membrane: the anchor cell breaches the barrier.

Authors:  Elliott J Hagedorn; David R Sherwood
Journal:  Curr Opin Cell Biol       Date:  2011-05-31       Impact factor: 8.382

4.  Overexpression and biological function of MEF2D in human pancreatic cancer.

Authors:  Zhiwang Song; Chan Feng; Yonglin Lu; Yong Gao; Yun Lin; Chunyan Dong
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 5.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

6.  Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases.

Authors:  Pratima Nangia-Makker; Tirza Raz; Larry Tait; Malathy P V Shekhar; Hong Li; Vitaly Balan; Hemanckur Makker; Rafael Fridman; Krishnarao Maddipati; Avraham Raz
Journal:  Cancer Biol Ther       Date:  2013-02-04       Impact factor: 4.742

7.  Enhanced potency of the metalloprotease inhibitor TAPI-2 by multivalent display.

Authors:  Aram J Raissi; Frank A Scangarello; Kaitlin R Hulce; Jason K Pontrello; Suzanne Paradis
Journal:  Bioorg Med Chem Lett       Date:  2014-02-14       Impact factor: 2.823

Review 8.  Molecular deconstruction, detection, and computational prediction of microenvironment-modulated cellular responses to cancer therapeutics.

Authors:  Mark A Labarge; Bahram Parvin; James B Lorens
Journal:  Adv Drug Deliv Rev       Date:  2014-02-26       Impact factor: 15.470

9.  Dynamics of M1 macrophages in oral mucosal lesions during the development of acute graft-versus-host disease in rats.

Authors:  K Seno; M Yasunaga; H Kajiya; K Izaki-Hagio; H Morita; M Yoneda; T Hirofuji; J Ohno
Journal:  Clin Exp Immunol       Date:  2017-09-28       Impact factor: 4.330

10.  IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages.

Authors:  Poonam Kothari; Roberto Pestana; Rim Mesraoua; Rim Elchaki; K M Faisal Khan; Andrew J Dannenberg; Domenick J Falcone
Journal:  J Immunol       Date:  2013-11-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.